Picture of Abionyx Pharma SA logo

ABNX — Abionyx Pharma SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Abionyx Pharma Announces Positive Signals In ATUN For Ultra-Rare Kidney Disease

Nov 25 (Reuters) - ABIONYX PHARMA SA  ABNX.PA :
    * ANNOUNCES OBSERVATION OF POSITIVE THERAPEUTIC SIGNALS IN
TEMPORARY AUTHORIZATIONS FOR USE (ATUN) IN FRANCE AND ITALY FOR
AN ULTRA-RARE KIDNEY DISEASE
    * EXCELLENT TOLERABILITY OF CER-001
    * ABIONYX IS AWAITING DATA FROM OTHER ONGOING PRECLINICAL
STUDIES

Source text for Eikon:  ID:nNDL37D39M 
Further company coverage:  ABNX.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Abionyx Pharma SA

See all news